Unknown

Dataset Information

IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis.


ABSTRACT:

Background

Accurate assessment of atopic dermatitis (AD) severity is critical when initiating and monitoring therapy. Use of existing research tools such as the Eczema Area and Severity Index (EASI) and Scoring Atopic Dermatitis (SCORAD) is complex and time-consuming in clinical practice. A previous analysis found the product of validated Investigator's Global Assessment (vIGA) and affected body surface area (BSA) to be an accurate and practical tool for routine assessment of paediatric AD.

Objective

To evaluate the IGAxBSA composite as an alternative to EASI or SCORAD for assessment of AD disease severity and disease responsiveness.

Methods

The relationship between IGAxBSA, EASI and SCORAD was assessed in a post hoc analysis of pooled data from the dupilumab clinical

SUBMITTER: Paller AS 

PROVIDER: S-EPMC9303952 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature